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Abstract
Background: Readily accessible samples such as peripheral blood or cell lines are increasingly being used in large
cohorts to characterise gene expression differences between a patient group and healthy controls. However, cell
and RNA isolation procedures and the variety of cell types that make up whole blood can affect gene expression
measurements. We therefore systematically investigated global gene expression profiles in peripheral blood from
six individuals collected during two visits by comparing five of the following cell and RNA isolation methods:
whole blood (PAXgene), peripheral blood mononuclear cells (PBMCs), lymphoblastoid cell lines (LCLs), CD19 and
CD20 specific B-cell subsets.
Results: Gene expression measurements were clearly discriminated by isolation method although the
reproducibility was high for all methods (range r = 0.90-1.00). The PAXgene samples showed a decrease in the
number of expressed genes (P < 1*10
-16) with higher variability (P < 1*10
-16) compared to the other methods.
Differentially expressed probes between PAXgene and PBMCs were correlated with the number of monocytes,
lymphocytes, neutrophils or erythrocytes. The correlations (r = 0.83; r = 0.79) of the expression levels of detected
probes between LCLs and B-cell subsets were much lower compared to the two B-cell isolation methods (r =
0.98). Gene ontology analysis of detected genes showed that genes involved in inflammatory responses are
enriched in B-cells CD19 and CD20 whereas genes involved in alcohol metabolic process and the cell cycle were
enriched in LCLs.
Conclusion: Gene expression profiles in blood-based samples are strongly dependent on the predominant
constituent cell type(s) and RNA isolation method. It is crucial to understand the differences and variability of gene
expression measurements between cell and RNA isolation procedures, and their relevance to disease processes,
before application in large clinical studies.
Background
T h ea d v e n to fm i c r o a r r a yt e c h n o l o g yh a sl e dt og e n -
ome-wide interrogation of transcript abundance.
Numerous studies have characterised variation in
human gene expression associated with cell and tissue
type, environmental conditions or disease and these
have led to a better understanding of biological path-
ways. For clinical purposes, gene expression signatures
have been useful to classify tumours [1,2], to identify
diagnostic markers [3] or patient groups that benefit
from therapies [4] and to understand infectious disease
processes [5].
Alongside genome-wide association studies and
upcoming sequencing studies, there is increasing interest
in obtaining large-scale “omics” data from large bio-
banks and sample collections, including gene expression,
proteomic and metabonomic profiling. These biobanks
will rely on easy sample collection and handling using
robust methodologies and sample storage over a pro-
longed time period. While the downstream gene expres-
sion profiling techniques using microarrays are very
reliable for large-scale investigations, there are still chal-
lenges prior to microarray analysis including the choice
o far e l e v a n ts a m p l et y p ea n dR N Aa n dc e l li s o l a t i o n
method. Blood-based samples will continue to be one of
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studies in large-scale investigations. Several strategies -
ranging from PAXgene (which captures RNA profiles of
all cell types in whole blood and has no complex cell
isolation procedures prior to RNA isolation) to the crea-
tion of lymphoblastoid cell lines (LCLs) comprising a
transformed single cell type - have been developed.
Other isolation methods attempt to generate a subset of
cell types such as peripheral blood mononuclear cells
(PBMCs) by the use of Ficoll or lymphocyte subsets
using magnetic beads.
Peripheral blood contains a variety of cell types
including erythrocytes, granulocytes, lymphocytes,
monocytes, natural killer cells and platelets. In PBMCs,
several cell types including neutrophils, basophils, eosi-
nophils, platelets, reticulocytes and erythrocytes are
depleted. Because each of the contributing cell types
expresses a unique gene expression signature relating to
its function, the relative proportions of the cell types
affect the gene expression profile [6]. In addition, the
relative proportions of the cell types can change rapidly
following disease-related or inflammatory responses.
Clearly, this variability may confound the interpretation
of gene expression differences between control and dis-
ease groups.
Investigating gene expression profiles in homogeneous
cell populations, such as T or B lymphocytes, that have
a potential as markers of infection or disease, might
resolve such variability and could have greater diagnos-
tic power than whole blood profiles [6,7]. The extraction
of more homogeneous cell populations, however, which
is often laborious and difficult to standardize, involves
manipulation of the cells and may influence the expres-
sion profiles [6-9].
One source that is used extensively to study genetic
influences on expression [10-12] or to investigate host
responses to pathogens [5] is LCLs. The substantial
advantage of LCLs over whole blood is that the impact
of environmental influences or other cell types on
expression is much reduced, allowing - in theory - a
more powerful investigation of genetic influences. How-
ever, LCLs are transformed and cultured under artificial
conditions and may not represent the natural gene
expression state in vivo due to a large percentage of
pauciclonality combined with widespread monoallelic
expression [13,14].
In order for gene expression profiling in blood to
become a reliable and reproducible tool in large-scale
investigations, a better understanding of intra- and
interindividual variability comparing used methods is
needed. Several studies have shown that the PAXgene
system using whole blood samples results in higher
variability of gene expression profiles and a decrease in
expressed genes compared to PBMC-based methods
[6-9]. However, Whitney et al. observed a higher varia-
bility of gene expression profiles in individuals with dis-
ease than among healthy individuals in blood, indicating
the feasibility of using gene expression profiling in blood
for disease detection and diagnosis [6].
Several studies have examined the variability and gene
expression signatures in whole blood and PBMCs in
healthy individuals using different cell and RNA isola-
tion procedures [6-8,15-21]. Only one study investigated
gene expression signatures of purified T- and B-lympho-
cytes and granulocytes [9] and little work has been done
to explore differences in gene expression profiles from
LCLs and B cell subsets. A comparison between the
variability and gene expression signature of LCLs to
other blood-based subtypes is of particular relevance,
given the extent to which this sample type is currently
being used for expression Quantitative Trait Loci studies
[10-12].
In the present study, we investigated variability and
consistency in gene expression profiles between five of
the most common post venipuncture methods of cell
and RNA isolation: whole blood (PAXgene (PAX)),
PBMCs, Epstein-Barr virus (EBV) transformed LCLs,
CD19-specific B-cells subsets (B-cell CD19), CD20-spe-
cific B-cells subsets (B-cell CD20). Using samples from
six individuals collected during two visits, we evaluated
the differences and concordances of global gene expres-
sion profiles, the biological and technical variability seen
in these approaches, cell-type specific gene expression
signatures and their relevance to large-scale biobanking
initiatives.
Results and Discussion
High reproducibility between visits and high variability
between methods
To determine the effect of the cell and RNA isolation
method on global gene expression profiling, gene
expression profiles for 56 out of 60 samples were suc-
cessfully generated on Illumina Ref 6 arrays (see Meth-
ods). The study design is shown in Figure 1. Four
samples failed gene expression profiling probably due to
low yield or low quality (see Additional file 1). Remain-
ing samples were checked using unsupervised analysis
(see Methods).
To evaluate the reproducibility, variability and signal-
noise ratio between the five cell and RNA isolation
methods, we examined variability between visits and
probes. To explore visit variability (intra-individual), we
calculated Spearman rank sum correlations between the
two visits across all probes after applying two common
probe filters (standard deviation (SD) and detection
score). The correlations ranged between 0.86-0.92 for all
probes, 0.83-0.90 for probes with SD > 0.5 and 0.90-1.00
for probes with detection score > 0.95 indicating a
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Figure 1 Study design. We obtained gene expression profiles of five different post venipuncture methods of cell and RNA isolation. The pie
charts illustrate the different cellular composition of the five methods whereas the arrows show the laboratory processes.
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Page 3 of 14higher reproducibility between visits using the detection
s c o r ea sap r o b ef i l t e r( T a b l e1 ) .T h e s ec o r r e l a t i o n s
(same individual) were higher than between random
individuals. Although PAX showed a high reproducibil-
ity between visits, it provided significantly fewer
detected probes (N = 8,783, 19%) than the other isola-
tion methods (range = 10,672-12,122 probes, 23-26%;
P < 1*10
-16) (Table 1). The percentage of variable probes
(SD > 0.5) in PAX, however, was significantly
higher (73%) compared with the other methods (52%-65%;
P<1 * 1 0
-16).
Consistent with our findings, previous studies found a
reduction of detected probes, lower gene expression sig-
nals and increased inter-individual variability as com-
pared to PBMCs [7,8]. Because the main differences
between PAX and PBMCs are the depletion of erythro-
cytes and reticulocytes from the latter, it is assumed
that these differences are related to the abundant
mRNA expression of members of the hemoglobin gene
family [8,22-25]. Previous studies have shown that
d e p l e t i o no fg l o b i nm R N Ar e s u l t e di na ni n c r e a s e d
number of detected probes, a decrease of variability and
improved detection sensitivity for mRNAs from non-
reticulocyte cell types [8,22-27] but we did not specifi-
cally test this option in the present study.
We next calculated the mean expression values across
individuals and visits for each overlapping detected
probe between four pairs of cell and RNA isolation
methods with (partly) corresponding or closely related
cell types to visualize inter-individual variability: i) PAX
and PBMCs, ii) LCLs and B-cell CD19, iii) LCLs and
B-cell CD20, and iv) B-cell CD19 and B-cell CD20
(Figure 2). The PAX expression levels are decreased
but more variable than the PBMC expression levels
(r = 0.85). The LCL expression levels are of similar
magnitude as the B-cell CD19 or B-cell CD20 expres-
sion levels (r =0 . 8 3a n dr = 0.79 respectively) but
lower than the correlation between B-cell CD19 and
CD20 (r = 0.98).
Variation in expression profiles between different iso-
lation methods and visits can originate from both
biological and technical sources. Inter-individual biologi-
cal variation can arise from variation such as genetic
variation, cellular compositio n ,e t h n i c i t y ,s e x ,g e n o t y p e -
environment interactions or physiological variation such
as time of the day at which a sample was taken, diet
and stress. The latter would also contribute to variability
between multiple visits [6,7,9-11,28]. Technical variation
can be caused by the different steps of the experiment
such as sample preparation, isolation of cellular compo-
nents, labelling, hybridisation and time to analysis
[6,7,9].
We found high correlations between visits for each
method (r = 0.96-0.99) but lower correlations between
different methods (r = 0.79-0.98) suggesting that the
cell or RNA isolation method has a larger impact on the
gene expression profile than the variability between vis-
its. The decreased correlations between LCLs and B-cell
CD19 or B-cell CD20 might have resulted from the con-
trolled in vitro conditions of the LCLs or the B-cell
purifications.
Methods that involve much post-processing provide
less variability but these manipulations might alter gene
expression patterns from those in vivo. The intrinsic
and extrinsic factors play a key role in choosing the
most preferable study design. In genetic studies, homo-
geneous cell populations - in which extrinsic factors are
minimized compared to ex vivo samples - are more use-
ful whereas for biomarker detection whole blood sam-
ples capturing in vivo conditions more accurately could
be more informative.
Gene expression profiles are dependent on cell and RNA
isolation method
To explore and visualise sources of variation in this
dataset, we clustered a subset of 7,305 probes that were
expressed in all 56 samples with a detection score >0.95
using principal components analysis (PCA) and hier-
archical clustering methods. Figure 3 shows that PCA
with three components separated the samples according
to the five methods. The first two components in the
PCA separated the PBMCs, B-cell CD19, B-cell CD20
Table 1 Variability and reproducibility after applying two common probe filters (detection score >0.95 and SD > 0.5)
for each RNA and cell isolation method.
RNA and cell isolation
method
No. of probes
with
SD > 0.5
No. of probes with
detection score
>0.95
Spearman correlation range
across replicates*
Mean(range)
Spearman correlation range across
random individuals
Mean(range)
PAX 34,012 8,783 0.96 (0.96-0.98) 0.93 (0.90-0.95)
PBMC 27,987 11,834 0.98 (0.90-0.99) 0.96 (0.93-0.97)
LCL 24,311 11,865 0.99 (0.96-1.0) 0.96 (0.96-0.97)
Bcell CD19 24,229 12,122 0.99 (0.98-0.99) 0.97 (0.93-0.96)
Bcell CD20 30,342 10,672 0.96 (0.93-0.98) 0.95 (0.96-0.97)
* Spearman correlations are calculated between two visits for each matched or random individual for each method. Spearman correlations are based on
detected probes.
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Page 4 of 14from PAX and LCLs explaining 70% of the variance.
The third component discriminated the PBMCs from B-
cell CD19 and B-cell CD20 explaining 9.8% of the var-
iance. Notably, B-cell CD19 and B-cell CD20 samples
were clustered together.
We computed Partial Least Squares Discriminant
Analysis (PLS-DA) models for each isolation method to
examine sets of genes whose transcripts are responsible
for separating the methods. For each model, we
extracted the variable weights of the expression probes,
ranked these variable weights and selected the 5% high-
est and 5% lowest ranked expression probes. Table 2
shows genes that were strongly up- or down-regulated
in the PLS-DA models.
These ten subsets of expression probes were then
analyzed for statistical enrichment of Gene Ontology
(GO) terms for Biological processes using all 7,305
expressed probes as a background list. The up-regu-
l a t e dp r o b e si nL C L sa n dt h ed o w n - r e g u l a t e dp r o b e s
of the B-cell CD20 samples (with an overlap of 50%
of probes) revealed an enrichment of alcohol meta-
bolic process (GO:0006066, False Discovery Rate
(FDR) P = 2.0*10
-7 and FDR P = 0.03) (see Additional
file 2).
Figure 2 Scatterplots of mean expression levels across individuals. Gene expression levels are averaged for the two visits of the
overlapping detected probes.
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Page 5 of 14Figure 3 Principal components analysis of the samples.
Table 2 Genes that were strongly up- or down-regulated for each cell and RNA isolation method.
RNA and cell isolation method Up-regulated genes Down-regulated genes
PAX SLC25A37, TYROBP, WDR40A RPL31, RPS27L, RPL26
PBMC NKG7, GZMB, SH2D1A CD70, TNFRSF13C,TNFRSF13B
LCL FSCN1, CD70, TNFSF9 FCRL3, RASGRP2,TYROBP
Bcell CD19 BANK1,FAM129C,FCRL3 LGALS3, WDR40A, FSCN1
Bcell CD20 BANK1,FAM129C, FCRL3 LGALS3, WDR40A, FSCN1
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Page 6 of 14The GO terms “response to wounding” (GO:0009611)
and “signal transduction” (GO:0007165) were enriched
in the down-regulated probes of the LCLs (FDR P =
0.02, FDR P = 1.2*10
-8) and the up-regulated probes of
the PAX (FDR P = 0.002; FDR P = 0.001) and PBMCs
(FDR P = 6.4*10
-4; FDR P = 8.7*10
-11). Hierarchical clus-
tering of the variable weights of the 2,072 down- and
up-regulated expression probes of all five methods
resulted in clustering of transcripts according to these
GO terms (Figure 4). To examine the concordance of
gene expression measurements across methods, we
extracted 1,952 expression probes that showed variable
weights between -0.01 and 0.01 for all methods. GO
analysis showed an enrichment of “secretion by cell”
(GO:0032940: FDR P 3.2*10
-3) and “antigen presentation
and processing” (GO:0048000, FDR P = 0.02).
Gene expression differences between isolation methods
are associated with cellular composition and B-cell
manipulation
Because PLS-DA analysis only gives an overview of varia-
tion for probes across all methods, we refined our GO
analysis by making pair-wise comparisons of closely
related isolation methods focusing on i) uniquely
detected probes and ii) overlapping detected probes that
were significantly differentially expressed between two
methods (Figure 5). In this analysis, we ranked the probes
on significance and then selected 5% of the most signifi-
cant probes that showed an at least three-fold change.
In the PAX-PBMC comparison, 456 probes were
detected in PAX but not in the PBMCs and 3,507 probes
vice versa. For the uniquely detected probes in the
PBMCs and PAX, none of the GO terms was significantly
Figure 4 Hierarchical clustering of 2,072 probes with 5% lowest and 5% highest PLS variable weights expressed across all 56 samples.
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Page 7 of 14enriched after FDR correction. We found 374 (4.5%)
probes differentially expressed between PAX and the
PBMCs (Table 3). These probes showed an enrichment
of “gas transport” (GO:0015669) containing genes CA2,
HBD and HBQ1 in PAX (Table 4). The GO term “Macro-
molecule biosynthetic process” (GO:0009059) was most
significantly enriched in the PBMCs containing 33 genes
(including GYPC, RPL26L1, EEF1B2, RPS27A, MTIF2)
encoding proteins such as ribosomal proteins, translation
initiation and elongation factors.
These findings suggest that the gene expression differ-
ences between the PBMCs and PAX are caused by the
differences in cellular composition; gas transport is
specific for erythrocytes and translation and transcrip-
tion are physiological responses more important in lym-
phocytes and monocytes than in granulocytes [6,9]. To
explore whether enrichment is derived from the most
abundant cell types in the sample, we clustered the dif-
ferentially expressed transcripts in six groups and corre-
lated the transcripts in each group to the cell counts in
whole blood (Figure 6). All three groups up-regulated in
the PBMCs showed significant positive correlations with
monocyte counts (r = 0.20, p = 2.2*10
-16; r =0 . 2 0 ,p=
2.7*10
-14; r = 0.29, p = 5.9*10
-7) and platelets (r =0 . 3 9 ,
p<1 0
-16; r = 0.42, p < 10
-16; r = 0.47, p = 6.6*10
-7).
Only one of these groups was correlated with lympho-
cytes (r = 0.36, p = 1.3*10
-7) whereas the two other
groups of up-regulated genes were significantly posi-
tively correlated with neutrophil count (r = 0.20, p =
1.3*10
-14; r = 0.50, p = 4.1*10
-11). Three groups of
probes were up-regulated in PAX containing probes tar-
geting “hemoglobin” and “signal transduction” genes
and the latter was significantly positively correlated with
erythrocyte count (r = 0.25, p = 2.5*10
-6) and mean cell
volume (r = 0.25, p = 8.3*10
-5) (Figure 7).
To prevent the difficulties of cell type mixtures, B-cell
specific methods have been developed. To investigate to
which extent B-cell specific methods differ from each
Figure 5 Venn diagrams of the number of detected probes between A) PAX and PBMCs B) B-cell CD19 and LCLs C) B-cell CD19 and
LCLs D) B-cell CD19 and B-cell CD20.
Table 3 The number of differentially expressed probes
between cell and RNA isolation methods after FDR
correction.
RNA and cell isolation method No. probes 5% top hits with three
fold change
+- %
PAX - PBMC 8,327 268 106 4.5
LCL - Bcell CD19 10,565 358 138 4.7
LCL - Bcell CD20 9,536 336 136 4.9
Bcell CD19 - CD20 10,411 13 18 0.3
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Page 8 of 14other, we compared gene expression measurements of
LCLs with B-cell CD19 and B-cell CD20. For the B-cell
CD19 and CD20, 1,557 and 1,136 probes were uniquely
expressed compared with the LCLs (Figure 5). In both
B-cell CD19 and CD20 the GO term (GO:0009611)
“response to wounding” (FDR P = 3.8*10
-9 and FDR P =
1.5*10
-11) was most significantly enriched. This category
contained B-cell specific genes encoding complement
pathway components (CD40lg, CD180), interleukins (IL-
6), chemokine receptors (CCR2, CCR3), immunoglobulin
receptors (FCER1G) and members of the toll-like recep-
tor family (TLR4, TLR8) (see Additional file 3).
In the LCLs, 1,300 and 2,329 probes were uniquely
expressed as compared to B-cell CD19 and CD20
(Figure 5). These probes showed an enrichment of the
GO term “Cell cycle phase” (GO:00022403, FDR P =
Table 4 Enrichment of GO terms among differentially expressed probes between different cell and RNA isolation
methods.
Go Term
(Biological Process)
Description No. genes (%) P FDR P
PAX versus PBMC
GO:0015669 Gas transport 6 (2.3) 2.1*10
-5 0.01
GO:0009059 Macromolecule biosynthetic process 33 (12.9) 8.3*10
-5 0.03
B-cell CD19 versus LCL
GO:0000278 Mitotic cell cycle 24 (6.2) 5.9*10
-5 0.02
GO:0006066 Alcohol metabolic process 23 (5.9) 3.6*10
-5 0.02
Bcell CD20 versus LCL
GO:0006066 Alcohol metabolic process 22 (6.5) 1.1*10
-5 0.02
Figure 6 Hierarchical clustering of 374 differentially expressed probes for the PAX and PBMCs.
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Page 9 of 140.005 and FDR P = 1.5*10
-4) and included genes
involved in mitosis (CCNB1, CENPF, PBK, TTK).
Between the B-cell CD19 or B-cell CD20 and LCL sam-
ples, 496 (4.7%) and 472 (4.9%) probes were differen-
tially expressed. In both B-cell CD19 and CD20 samples,
glycolysis GO terms were enriched whereas cell cycle
GO terms were only enriched in B-cell CD19 (Table 4).
The GO analysis suggested an increased rate of glycoly-
sis and cell cycle in LCLs as compared with B-cells. B
lymphocytes found in the peripheral circulation are in a
non-proliferative state and require stimulation with an
antigen to enter the cell cycle. Hollyoake et al. showed
that infection with EBV causes the infected cells to acti-
vate the cell-division cycle [29].
Conclusion
Gene expression profiling of blood is a valuable tool for
diagnostics in a wide range of diseases, particularly
those involving the immune system and cancer. Before
peripheral blood or cell lines can be used in large
cohorts to characterise differences between a patient
group and healthy controls, it is important to
Figure 7 Clusters of differentially expressed probes are correlated with several parameters of blood counts (number of neutrophils,
number of lymphocytes, number of erythrocytes, number of monocytes and mean cell volume). Open circles indicate outlying values in
PAX. Significance levels are indicated at the top: * p-values ≤ 0.05 and > 10
-5,** p-values are ≤ 10
-5 and >10
-10,*** p-values are ≤ 10
-10.
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tors that contribute to the gene expression measure-
ments. Our results give insight into the variability and
characterisation of biological differences between post
venipuncture methods including LCLs, purified B-cells
(CD19 and CD20), PBMCs and whole blood samples for
global gene expression profiling. The number of
expressed genes as well the gene expression measure-
ments differ significantly between different isolation
techniques. Although the PAXgene system is suitable
for large-scale gene expression profiling, particularly in
large epidemiological and biobank studies where
immediate sample processing is not always practical, the
PAX samples showed a decrease in the number of
expressed genes and lower gene expression values with
higher variability compared to the PBMCs. Although
whole blood samples contain more cell populations with
different relative proportions than PBMCs, expression
profile differences between the two isolation methods
are also likely to be (partly) caused by the abundance of
globin mRNA. Additional steps in the PAX protocol
involving globin reduction could improve sensitivity and
variability of this sample type relative to other isolation
methods [8,22-27].
The up-regulated probes in PBMCs showed significant
positive correlations with the number of monocytes,
lymphocytes and neutrophils, whereas the down-regu-
lated probes were correlated with the number erythro-
cytes and mean cell volume. Our comparison between
B-cell subsets and LCLs showed that the correlations
between the expression levels of detected probes were
much lower compared to the two B-cell isolation meth-
ods. More specifically, enrichment of inflammatory
response genes in the B-cell CD19 and CD20 may
represent the lack of external stimuli of the in vitro con-
trolled conditions in LCLs or the manipulation of the B-
cell CD19 and CD20. Conversely, the enrichment of gly-
colysis and cell cycle genes in LCLs might appear as
adaptation to the in vitro cell transformation of B-cells
to LCLs and might reflect indefinite LCL propagation.
In this study, we used two positive selection
approaches -using incubation of PBMCs with anti-CD19
or anti-CD20- to purify B-cell populations. A potential
limitation of these approaches is the activation of cell
surface receptors that might alter gene expression.
Further studies of gene expression profiles of other
more recently developed B-cell selection methods using
a negative selection approach should further improve
our understanding of gene expression variability in
blood [30].
Some of these cell and RNA isolation methods are
widely used in large-scale clinical studies; indeed, PAX-
gene is a likely to be a favoured method for general
whole blood expression profiling in samples stored in
large biobanking facilities. It is, however, crucial to con-
sider what effect the choice of a specific RNA isolation
procedure has on the ability to detect certain gene
expression profiles and their likely relation to the dis-
ease of interest.
Methods
Subjects and blood samples
Blood was taken from six healthy volunteers seen twice
in two weeks. All volunteers were Caucasian, healthy,
not on medication and non-fasted. Complete blood
counts were determined by standard procedures and
included: cell counts (white cells, erythrocytes, leuko-
cytes, platelets, neutrophils, lymphocytes, monocytes,
eosinophils and basophils), hemoglobin, hematocrit and
erythrocyte indices (mean corpuscular volume, mean
corpuscular hemoglobin and mean corpuscular hemo-
globin concentration). All subjects fell within normal
ranges for the major cell populations.
For each individual, five different post venipuncture
methods were performed (Figure 1). B Lymphocytes
from 10 ml of blood were isolated by tubes with sodium
citrate. LCLs were generated by EBV-mediated transfor-
mation and cells were grown for eight weeks.
For the isolation of CD19 and CD20 B-cells, 40 ml
whole blood from EDTA tubes was collected and
PBMCs were isolated by using a Ficoll-Paque™ gradient
(Amersham). CD19 and CD20 B-cells were prepared by
positive selection from the PBMCs by incubation with
magnetic anti-CD19 or CD20 mAb-coated microbeads
(MACS, Miltenyi Biotec). For the isolation of PBMCs
from whole blood, BD Vacutainer® CPT Mononuclear
Cell Preparation Tubes (Becton and Dickinson) were
used. Total RNA was isolated from 5 ml of whole blood
samples with the PAXGene Blood RNA system (QIA-
GEN) and samples were left at room temperature for 24
hours before processing according to manufacturer’s
instructions.
Only two people at a time were sampled on any one
day for logistical reasons. After blood draw standard
protocols were followed for cell isolation, transformation
or RNA extraction. With the exception of the PAXgene
samples all RNA was isolated using TRI™ reagent
(SIGMA) and resuspended in RNase free water.
This research was carried out in compliance with the
Helsinki Declaration, and was carried out under ethical
approvals granted to the MolPAGE project by Oxford-
shire Research Ethics Committee B (05/Q1605).
Pre-processing of microarray data
After RNA had been isolated successfully for 59 sam-
ples, RNA quantity was measured using a Nanodrop
ND-1000 Spectrophotometer to give the yield and a
260/280 ratio. Agilent Bioanalyser Lab-on-a-chip RNA
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by calculating RNA Integrity Number (RIN) scores. 500
ng of total RNA was labelled using the TotalPrep™ RNA
Amplification Kit (Ambion Inc.). For each of the five
methods, samples from two visits of an individual were
measured on the same Beadchip and samples from each
individual were measured on a maximum of three Bead-
chips to maximise biological reproducibility and mini-
mise technical variability.
Expression profiling was completed using Human-6
version 2 Sentrix BeadArrays (Illumina Inc.) which con-
tains 48,702 unique probes covering 28,567 RefSeq
annotated transcripts. Arrays were hybridised with
labelled cRNA material and scanned according to manu-
facturer’s instructions. The resultant data were parsed
with the software package BeadStudio (Illumina Inc.) to
produce raw intensity values for all probes. Signal was
checked for quality using hybridisation and labelling
controls internal to each array and subtracted for back-
ground within the statistical scripting environment, R
v2.4.1 [31]. Signal was transformed and normalised
using the variance stabilization algorithm as implemen-
ted in the vsn2 [32] Bioconductor [33] package. Trans-
formed and normalised signal distributions for each
sample were investigated with unsupervised analysis to
identify outliers.
Data quality, probe mapping and filtering
Gene expression profiling was successful for 56 out of
60 samples. RIN scores summarize the distribution of
molecular weights and low RIN scores may confound
further analyses. All four samples that failed showed a
very low RIN score. Due to the use of a different purifi-
cation method, we had no RIN scores available for the
LCLs. Five successfully arrayed samples with high repro-
ducibility between visits showed RIN scores between 1.5
and 6.5 (see Additional file 1). Hierarchical clustering
showed however that isolation method was the major
response variable and not RIN, yield, individual, chip,
detection score or visit.
Probes were sequence matched to NCBI Build 36.1
(hg18) using the blastn algorithm to obtain a physical
position from which Ensembl transcript and Gene iden-
tifiers were extracted. Probes that showed one mismatch
or more were aligned to Ensembl transcripts or EMBL
ESTs using BLAST (1), and genomic locations were
then established by re-mapping the target transcript to
genome (NCBI build 36) either by extracting annotation
data from UCSC MySQL tables or by BLAST against
genomic sequence. Probes overlapping at least 10 bases
of repeat sequence, established by using RepeatMasker
on the transcript sequence, were discarded. Probes with
SNPs (minor allele frequency > 5%, http://www.hapmap.
org) in their sequence or that had no match to the
human genome build 36 were removed from the analy-
sis. We could extract Ensembl transcripts identifiers for
a total of 21,855 probes.
Statistical analysis
For each method, data analysis was restricted to i)
probes for which the detection score was greater than
95% in all samples or ii) probes with SD > 0.5 in all
samples. We compared the number of detected probes
between methods by using a McNemar test. For investi-
gation of the biological reproducibility and the concor-
dance between methods, we calculated spearman
correlations between visits for each probe for each
method. To compare biological reproducibility between
two methods, we averaged the expression values of each
probes across visits and calculated spearman correla-
tions between methods.
For the clustering analysis, we used hierarchical clus-
tering and PCA (using the NIPALS algorithm for esti-
mating latent variables) on the normalised gene
expression data of 7,305 probes that were detected
across all 56 samples. In the PCA and PLS-DA analy-
sis, the measurements of each expression probe were
mean centered prior to the analysis. Using a PLS-DA
model, we identified a set of transcripts that discrimi-
nates the method of interest from the other four
methods. We computed a separate PLS-DA model for
each method for which we set two classes as a
response variable: one class for the method of interest
and one class for the other four methods. We then
extracted the w1 variable weights of the expression
probes for each of the five PLS-DA models, ranked
these variable weights and selected the 5% highest and
5% lowest ranked expression probes for each method.
For a single vector, y, Trygg et al. suggested, that w1
should contain more useful interpretational informa-
tion than the more commonly used regression coeffi-
cients [34].
To investigate the correlation between differentially
expressed probes and cellular composition, we per-
formed hierarchical clustering on the 374 differentially
expressed probes. For each cluster of probes, we calcu-
lated spearman correlations between each probe by
averaging the expression measurements of the two visits
of the PAX samples and cell count parameters (neutro-
phils, lymphocytes and monocytes, mean cell volume
and hemoglobin concentration). Subsequently, we com-
pared the mean spearman correlations of the probes in
each cluster with mean spearman correlation of all
detected probes excluding the differentially expressed
probes using a Wilcoxon rank-sum test. Multivariate
analyses were performed using Evince (UmBio). All
other analyses were conducted within the statistical
scripting environment, R v2.4.1 [31].
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We investigated significante n r i c h m e n to fs p e c i f i cG O
terms among the set of probes that are specific for the
method compared to the all probes detected for that
specific method. In all GO analyses, Ensembl Gene
Identifiers were tested using DAVID [35]. Enrichment of
each GO term was evaluated through use of the Fisher’s
exact Test and corrected for multiple testing with FDR
[36].
Differential expression analysis
We used the Bioconductor R package Maanova to iden-
tify expression probes whose expression differed signifi-
cantly between pairs of methods [37]. We fitted a linear
mixed model for each probe using the Fs distribution as
the null distribution and we fitted method as fixed, and
visit and individual as random effects. We considered
probes as differentially expressed when significant at a
5% FDR. We tested for significant enrichment of GO
terms among the set of differentially expressed probes
relative to the overlapping detected probes of two meth-
ods. Because a large proportion of probes were signifi-
cantly differentially expressed, we selected the 5% of top
hits ranked by FDR p-value. Of these 5% of top probes,
we used only these probes that showed a more than a
three fold change between methods.
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